Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Omeprazole on BMS-986205 PK in Healthy Subjects
NCT03936374Phase 1Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of linrodostat in solid tumor, sponsored by Bristol Myers Squibb. Primary endpoints: Maximum Observed Plasma Concentration, Area Under the Plasma Concentration-time Curve From Time Zero to Time of Last Quantifiable Concentration and 1 more. Started May 2019; status: completed.
02
Drugs
linrodostat
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03936374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03936374.